Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phenothiazine | HCID 7108 | — |
| Reactant | 1-Bromooctane | HCID 8140 | — |
| Reactant | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Reactant | HCID 22599025 | HCID 22599025 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 22599057 | HCID 22599057 | — |
Reaction Steps
A total of 0.2 g of a polymerization inhibitor (phenothiazine) was dissolved in N,N-dimethylformamide. To the resulting solution were added and dissolved 0.62 g (0.0032 mol) of octyl bromide, 2.5 g (0.016 mol) of 1,8-diazabicyclo[5.4.0]-7-undecene (DBU), and 1 g (0.0032 mol) of the above-prepared 1-[4-(9-decenyloxy)phenyl]piperazine, followed by a reaction at 60° C. in an atmosphere of nitrogen gas for 48 hours with stirring. After completion of the reaction, the solution was poured into ice water, extracted with two portions of 300 mL of diethyl ether, washed with 300 mL of distilled water and dehydrated over anhydrous sodium sulfate overnight. After filtration, the solution was diluted with hexane and separated into soluble matters and insoluble matter. The hexane-soluble matter was then recrystallized from ether and hexane (1:3) and thereby yielded the target compound, 1-[4-(9-decenyloxy)phenyl]-4-octylpiperazine.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06838129B2 |
|---|
| Source dataset | uspto-grants-2005_01 |
|---|
| ORD ID | ord-cc9d001da0b345eeb893692fa1a28cef |
|---|
| Source note | uspto-grants-2005_01 |
|---|